MyMD Pharmaceuticals Inc (MYMD): please post if u have any idea why we do...

Reply Private New

Replies (2) Next 10 Prev Next

Send PM Follow Ignore

Followers	16
Posts	923
Boards Moderated	0
Alias Born	01/10/2008

kishmech

Re: kishmech post# 214

Monday, 12/13/2021 7:48:15 PM

Monday, December 13, 2021 7:48:15 PM

please post if u have any idea why we dont see some bigger buys here on a daily basis i think this could be a 50 dollar stock in a few months

Keep Last Read

Replies (2) Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Recent MYMD News

Form 8-K - Current report • Edgar (US Regulatory) • 06/17/2024 01:04:23 PM
MyMD Pharmaceuticals Appoints Accomplished Biopharmaceutical Leader and Current Board Member, Mitchell Glass, M.D. as President and Chief Medical Officer • Business Wire • 06/17/2024 01:00:00 PM
Form D - Notice of Exempt Offering of Securities • Edgar (US Regulatory) • 05/31/2024 12:00:27 PM
Form 8-K - Current report • Edgar (US Regulatory) • 05/23/2024 08:05:25 PM
Form 8-K - Current report • Edgar (US Regulatory) • 05/21/2024 01:10:03 PM
MyMD Pharmaceuticals Secures Strategic Investments • Business Wire • 05/21/2024 01:00:00 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/15/2024 09:01:08 PM
Form 8-K - Current report • Edgar (US Regulatory) • 03/07/2024 09:30:39 PM
Form 8-K - Current report • Edgar (US Regulatory) • 03/05/2024 04:00:19 PM
MyMD Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Requirement for Continued Listing • Business Wire • 03/05/2024 02:15:00 PM
Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/14/2024 08:13:35 PM
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 04:27:33 PM
Form 8-K - Current report • Edgar (US Regulatory) • 02/13/2024 09:57:03 PM
MyMD Pharmaceuticals Announces Reverse Stock Split to Maintain Nasdaq Listing • Business Wire • 02/13/2024 04:45:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/06/2023 02:15:12 PM
MyMD Pharmaceuticals Plans FDA-Cleared Phase 2 Clinical Trial of MYMD-1 in Rheumatoid Arthritis • Business Wire • 12/06/2023 02:15:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/19/2023 01:00:10 PM
MyMD Announces Preclinical Study Results Showing Novel Cannabidiol Analog, Supera-CBD™, Reduced Acute Inflammatory Pain • Business Wire • 10/19/2023 01:00:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/13/2023 09:00:16 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/04/2023 08:30:23 PM
MyMD Pharmaceuticals to Present Updated Statistically Significant Phase 2 Data for MYMD-1, Potential TNF-α Market Disrupter, at BioFuture 2023 • Business Wire • 10/04/2023 11:30:00 AM
Form 8-K - Current report • Edgar (US Regulatory) • 09/08/2023 09:24:39 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/24/2023 09:58:33 PM

More MYMD News

InvestorsHub NewsWire

Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM

VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM

North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM

Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM

POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM

HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM

Start posting your company's news

Only $200 per official company press release!

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover